In a regulatory filing, Compugen (CGEN), through its U.S. subsidiary, currently holds approximately 1.3% of its cash and cash equivalents with SVB, and considers its exposure to any liquidity concern at SVB (SIVB) as immaterial.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CGEN:
- Compugen doses first patient in proof-of-concept study evaluating COM701
- Compugen reports Q4 EPS (4c), consensus (14c)
- Compugen: Rilvegostomig expected to progress into Phase 3 this year
- Compugen downgraded to Underperform from Hold at Jefferies
- Compugen participates in a conference call with JMP Securities
